ALCEDIAG has a total of 27 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and China. Its main competitors in its focus markets biotechnology, measurement and computer technology are UNIV ROSTOCK ZENTRALE UNIVSVERWALTUNG REFERAT 1 1 RECHT, PACIFIC EDGE LTD and CHENGDU TECBOND BIOLOG PRODUCTS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | China | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | Hungary | 2 | |
#8 | Australia | 1 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Computer technology | |
#4 | Micro-structure and nano-technology | |
#5 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Weissmann Dinah | 21 |
#2 | Pujol Jean-François | 13 |
#3 | Salvetat Nicolas | 11 |
#4 | Van Der Laan Siem | 11 |
#5 | Cavarec Laurent | 10 |
#6 | Vincent Laurent | 10 |
#7 | Molina Franck | 8 |
#8 | Pujol Jean-Francois | 8 |
#9 | Vire Berangere | 6 |
#10 | Dinah Weissmann | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020249823A1 | Nano-rheological biomarkers for early and improved follow-up of pathologies associated to rbc deformability alteration | |
AU2017302132A1 | RNA editing as biomarkers for mood disorders test | |
CN109074422A | The method and its purposes in diagnosis for preparing biosynthesis device | |
CN108779494A | Select the algorithm and in-vitro method based on rna editing of the specific effect induced by reactive compound |